South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> Global Fund Investigating Karachi Private Hospital For US$ 4.2 Million In Misallocations Of TB Funds 26/02/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD, PAKISTAN – EXCLUSIVE – The Global Fund to fight HIV/AIDS, Tuberculosis and Malaria and Pakistan’s Health Ministry are investigating a private sector hospital in Karachi for alleged mismanagement of some US$ 4.2 million in Global Fund funds allocated to the country for tuberculosis elimination (TB) activities. The Indus Hospital (TIH), the principal recipient of […] Continue reading -> Global Citizen Launches ‘Recover Better Together’ Campaign – Guinea Launches Ebola Vaccinations – Nigeria & Zambia Studies Show High SARS-CoV2 Infections 23/02/2021 Kerry Cullinan Vaccinating all of Africa’s health workers would need half a percent of all the doses that the G-7 countries have purchased, according to Global Citizen CEO Hugh Evans. On Tuesday, Global Citizen launched a five-point ‘Recover Better Together’ plan for the world, aimed at getting millions of citizens behind ending COVID-19 for all, ending the […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Global Fund Investigating Karachi Private Hospital For US$ 4.2 Million In Misallocations Of TB Funds 26/02/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD, PAKISTAN – EXCLUSIVE – The Global Fund to fight HIV/AIDS, Tuberculosis and Malaria and Pakistan’s Health Ministry are investigating a private sector hospital in Karachi for alleged mismanagement of some US$ 4.2 million in Global Fund funds allocated to the country for tuberculosis elimination (TB) activities. The Indus Hospital (TIH), the principal recipient of […] Continue reading -> Global Citizen Launches ‘Recover Better Together’ Campaign – Guinea Launches Ebola Vaccinations – Nigeria & Zambia Studies Show High SARS-CoV2 Infections 23/02/2021 Kerry Cullinan Vaccinating all of Africa’s health workers would need half a percent of all the doses that the G-7 countries have purchased, according to Global Citizen CEO Hugh Evans. On Tuesday, Global Citizen launched a five-point ‘Recover Better Together’ plan for the world, aimed at getting millions of citizens behind ending COVID-19 for all, ending the […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Global Citizen Launches ‘Recover Better Together’ Campaign – Guinea Launches Ebola Vaccinations – Nigeria & Zambia Studies Show High SARS-CoV2 Infections 23/02/2021 Kerry Cullinan Vaccinating all of Africa’s health workers would need half a percent of all the doses that the G-7 countries have purchased, according to Global Citizen CEO Hugh Evans. On Tuesday, Global Citizen launched a five-point ‘Recover Better Together’ plan for the world, aimed at getting millions of citizens behind ending COVID-19 for all, ending the […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Low-Income Countries Can Expect Higher Mortality From ‘Collateral Damage’ Than COVID-19, Global Fund Head Predicts 26/01/2021 J Hacker While very low-income countries have experienced relatively low mortality rates from COVID-19, they can expect higher mortality caused by the knock-on effects of the pandemic on their fragile health systems, according to the Executive Director of the Global Fund to Fight AIDS, TB and Malaria. Since the pandemic first overwhelmed health systems in early 2020, […] Continue reading -> Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Pandemic Perils: How Battling One Deadly Disease May Intensify Risks From Others 21/01/2021 Jamie Bay Nishi The demands of fighting the COVID-19 pandemic are draining resources from global health research and development (R&D) programs and disrupting clinical trials and other work, presenting a potential post-pandemic scenario of a world more vulnerable to a host of infectious threats. That’s what our organization, the Global Health Technologies Coalition (GHTC), learned after conducting extensive, […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts
Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Posts navigation Older postsNewer posts